Low-intensity swimming training after weaning improves glucose and lipid homeostasis in MSG hypothalamic obese mice

Endocrine Research

Volumn 36, Issue 2, 2011, Pages 83-90

  Scomparin, Dionízia Xavier ^a   Grassiolli, Sabrina ^a   Gomes, Rodrigo Mello ^a   Torrezan, Rosana ^a   De Oliveira, Júlio Cezar ^a   Gravena, Clarice ^a   Pêra, Carolina Costa ^a   De Freitas Mathias, Paulo Cezar ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

glycemic homeostasis; lipid profile; metabolic syndrome; MSG obese mice; swim training

Indexed keywords

CHOLESTEROL; GLUCOSE; GLUTAMATE SODIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BODY GROWTH; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; EXERCISE; EXERCISE INTENSITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HOMEOSTASIS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; LIPID HOMEOSTASIS; LIPID STORAGE; LOW INTENSITY SWIMMING; MALE; METABOLISM; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RELAXATION TRAINING; SWIMMING; TRIACYLGLYCEROL BLOOD LEVEL; WEANING;

ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HYPOTHALAMIC DISEASES; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; PHYSICAL CONDITIONING, ANIMAL; SODIUM GLUTAMATE; SWIMMING;

EID: 79955679077     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2010.534750     Document Type: Article

References (42)

1. Shaw DI, Hall WL, Williams CM. Metabolic syndrome: what is it and what are the implications? Proc Nutr Soc 2005;64:349-357. (Pubitemid 41160764)
2. Weiss R, Caprio S. The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 2005;19:405-419. (Pubitemid 41263795)
3. Dietz WH. Childhood weight affects adult morbidity and mortality. J Nutr 1998;128:411S-414S. (Pubitemid 28090393)
4. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-1812. (Pubitemid 44033300)
5. Grassiolli S, Gravena C, de Freitas Mathias PC. Muscarinic M2 receptor is active on pancreatic islets from hypothalamic obese rat. Eur J Pharmacol 2007;556:223-228. (Pubitemid 46074015)
6. Coenen KR, Hasty AH. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Am J Physiol Endocrinol Metab 2007;293:E492-E499. (Pubitemid 47205092)
7. Liu RH, Mizuta M, Kurose T, Matsukura S. Early events involved in the development of insulin resistance in Zucker fatty rat. Int J Obes Relat Metab Disord 2002;26:318-326. (Pubitemid 34226156)
8. Mathe D. Dyslipidemia and diabetes: animal models. Diabete Metab 1995;21:106-111.
9. de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR 2001;33:63-71. (Pubitemid 33639419)
10. Xu L, Zhao Y, Zhan SQ, et al. Temporal and spatial expression of preprotachykinin A mRNA in the developing filial mice brain after maternal administration of monosodium glutamate at a late stage of pregnancy. Neuroscience 2007;145:974-980. (Pubitemid 46454352)
11. Semprini ME, Conti L, Ciofi-Luzzatto A, Mariani A. Effect of oral administration of monosodium glutamate (MSG) on the hypothalamic arcuate region of rat and mouse: a histological assay, Biomedicine 1974;21:398-403.
12. Macho L, Fickova M, Jezová, Zorad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res 2000; 49 Suppl 1:S79-S85. (Pubitemid 30399355)
13. Maletinska L, Toma RS, Pirnik Z, et al. Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice. Regul Pept 2006;136:58-63.
14. Machado UF, Shimizu Y, Saito M. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice. Horm Metab Res 1993;25:462-465. (Pubitemid 23274566)
15. Lucinei Balbo S, Gravena C, Bonfleur ML, de Freitas Mathias PC. Insulin secretion and acetylcholinesterase activity in monosodium l-glutamate-induced obese mice. Horm Res 2000;54:186-191.
16. Martins ACP, Borges HE, Garcia RMG, Carniatto SR, Mathias PCF. Monossodium L-glutamateinduced obesity impaired the adrenal medullae activity. Neurosci Res Commun 2001;28:49-57.
17. Bray GA. Genetic, hypothalamic and endocrine features of clinical and experimental obesity. Prog Brain Res 1992;93:333-340; discussion 340-331.
18. Balbo SL, Bonfleur ML, Carneiro EM, Amaral ME, Filiputti E, Mathias PC. Parasympathetic activity changes insulin response to glucose and neurotransmitters. Diabetes Metab 2002;28: 3S13-3S17; discussion 13S108-13S112. (Pubitemid 36077133)
19. Campfield LA, Smith FJ, Larue-Achagiotis C. Temporal evolution of altered islet neurotransmitter sensitivity after VMH lesion. Am J Physiol 1986;251:R63-R69.
20. Jeanrenaud B. Neuro-endocrine disorders in obesity. Int J Vitam Nutr Res Suppl 1986;29:41-48.
21. Mitrani P, Srinivasan M, Dodds C, Patel MS. Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. Am J Physiol Endocrinol Metab 2007.
22. Adamu B, Sani MU, Abdu A. Physical exercise and health: a review. Niger J Med 2006;15:190-196.
23. Bray GA, Champagne CM. Obesity and the Metabolic Syndrome: implications for dietetics practitioners. J Am Diet Assoc 2004;104:86-89. (Pubitemid 38058304)
24. Israili ZH, Lyoussi B, Hernandez-Hernandez R, Velasco M. Metabolic syndrome: treatment of hypertensive patients. Am J Ther 2007;14:386-402. (Pubitemid 47224822)
25. Scomparin DX, Grassiolli S, Marcal AC, Gravena C, Andreazzi AE, Mathias PC. Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium L-glutamate-obesity onset in mice. Life Sci 2006;79:2151-2156. (Pubitemid 44573279)
26. Moura AS, Carpinelli AR, Barbosa FB, Gravena C, Mathias PC. Undernutrition during early lactation as an alternative model to study the onset of diabetes mellitus type II. Res Commun Mol Pathol Pharmacol 1996;92:73-84. (Pubitemid 26149854)
27. Napoli C, Williams-Ignarro S, De Nigris F, et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004;101:8797-8802. (Pubitemid 38745851)
28. Bernardis LL, Patterson BD. Correlation between "Lee Index" and carcass fat content in weanling and adults female rats with hypothalamic lesions. J. Endocrinol. 1968;40:527-528.
29. Olney JW. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721.
30. Iwase M, Yamamoto M, Iino K, et al. Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: an animal model of multiple risk factors. Hypertens Res 1998;21:1-6.
31. Diniz YS, Faine LA, Galhardi CM, et al. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition 2005;21:749-755. (Pubitemid 40733571)
32. Dawson R, Jr. Acute and long lasting neurochemical effects of monosodium glutamate administration to mice. Neuropharmacology 1983;22:1417-1419. (Pubitemid 14222239)
33. Acs Z, Antoni FA, Makara GB. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate. J Endocrinol 1982;93:239-245. (Pubitemid 12161589)
34. Dawson R Jr., Lorden JF. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice. J Comp Physiol Psychol 1981;95:71-84.
35. Cameron DP, Poon TK, Smith GC. Effects of monosodium glutamate administration in the neonatal period on the diabetic syndrome in KK mice. Diabetologia 1976;12:621-626.
36. terAvest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia. Clin Sci (Lond) 2007;112:131-139. (Pubitemid 46120092)
37. Su CF, Chang YY, Pai HH, Liu IM, Lo CY, Cheng JT. Mediation of beta-endorphin in exerciseinduced improvement in insulin resistance in obese Zucker rats. Diabetes Metab Res Rev 2005;21:175-182. (Pubitemid 40467664)
38. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci 2002;71:1917-1928. (Pubitemid 34880236)
39. Scomparin DX, Gomes RM, Grassiolli S, Oliveira JC, Gravena C, Mathias PCF. Monosodium L-glutamate (MSG)-induced obesity provokes autonomic changes. Endocrinol Diabetes Clin Exp 2009;9:3.
40. Patterson CM, Dunn-Meynell AA, Levin BE. Three weeks of early-onset exercise prolongs obesity resistance in DIO rats after exercise cessation. Am J Physiol Regul Integr Comp Physiol 2008;294:R290-R301. (Pubitemid 351213733)
41. Eadie BD, Redila VA, Christie BR. Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J Comp Neurol 2005;486:39-47. (Pubitemid 40571648)
42. Redila VA, Christie BR. Exercise-induced changes in dendritic structure and complexity in the adult hippocampal dentate gyrus. Neuroscience 2006;137:1299-1307. (Pubitemid 43133154)